162 related articles for article (PubMed ID: 38631437)
1. Incorporating functional genomics into the pathology-supported genetic testing framework implemented in South Africa: A future view of precision medicine for breast carcinomas.
Christowitz C; Olivier DW; Schneider JW; Kotze MJ; Engelbrecht AM
Mutat Res Rev Mutat Res; 2024; 793():108492. PubMed ID: 38631437
[TBL] [Abstract][Full Text] [Related]
2. Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa.
Kotze M
S Afr Med J; 2016 May; 106(6 Suppl 1):S114-8. PubMed ID: 27245544
[TBL] [Abstract][Full Text] [Related]
3. Genomic medicine and risk prediction across the disease spectrum.
Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
[TBL] [Abstract][Full Text] [Related]
4. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
[TBL] [Abstract][Full Text] [Related]
5. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
[TBL] [Abstract][Full Text] [Related]
6. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks.
Brnich SE; Rivera-Muñoz EA; Berg JS
Hum Mutat; 2018 Nov; 39(11):1531-1541. PubMed ID: 30095857
[TBL] [Abstract][Full Text] [Related]
7. Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
van der Merwe N; Peeters AV; Pienaar FM; Bezuidenhout J; van Rensburg SJ; Kotze MJ
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241424
[TBL] [Abstract][Full Text] [Related]
8. Will variants of uncertain significance still exist in 2030?
Fowler DM; Rehm HL
Am J Hum Genet; 2024 Jan; 111(1):5-10. PubMed ID: 38086381
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
Ipe J; Swart M; Burgess KS; Skaar TC
Clin Transl Sci; 2017 Mar; 10(2):67-77. PubMed ID: 28213901
[No Abstract] [Full Text] [Related]
10. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for
Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D
J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042
[TBL] [Abstract][Full Text] [Related]
11. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
13. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
[TBL] [Abstract][Full Text] [Related]
14. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization.
Nicora G; Zucca S; Limongelli I; Bellazzi R; Magni P
Sci Rep; 2022 Feb; 12(1):2517. PubMed ID: 35169226
[TBL] [Abstract][Full Text] [Related]
15. Reclassification of
Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
[TBL] [Abstract][Full Text] [Related]
16. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
[TBL] [Abstract][Full Text] [Related]
17. Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
Kim HK; Lee EJ; Lee YJ; Kim J; Kim Y; Kim K; Lee SW; Chang S; Lee YJ; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
J Hum Genet; 2020 Mar; 65(3):209-220. PubMed ID: 31907386
[TBL] [Abstract][Full Text] [Related]
18. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.
Morales A; Kinnamon DD; Jordan E; Platt J; Vatta M; Dorschner MO; Starkey CA; Mead JO; Ai T; Burke W; Gastier-Foster J; Jarvik GP; Rehm HL; Nickerson DA; Hershberger RE; ;
Circ Genom Precis Med; 2020 Apr; 13(2):e002480. PubMed ID: 32160020
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
[TBL] [Abstract][Full Text] [Related]
20. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.
Federici G; Soddu S
J Exp Clin Cancer Res; 2020 Mar; 39(1):46. PubMed ID: 32127026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
